A Drug-drug Interaction Study of SHR2150 on Healthy Chinese Volunteers

NCT05141422 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Immunodeficiency Virus Infection

Interventions

DRUG: SHR2150 tablet、efavirenz

Sponsor

Jiangsu HengRui Medicine Co., Ltd.